These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7242779)

  • 41. Myelin associated glycoprotein (MAG) in Wallerian degeneration of the optic nerve.
    Wender M; Wajgt A; Michałowska G; Tokarz E
    Exp Pathol; 1984; 25(2):125-7. PubMed ID: 6202545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myelination of regenerating sciatic nerve of the rat: lipid components and synthesis of myelin lipids.
    Alberghina M; Viola M; Moschella F; Giuffrida AM
    Neurochem Res; 1983 Feb; 8(2):133-50. PubMed ID: 6190098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incorporation of leucine metabolites into brain and sciatic nerve myelin.
    Wiggins RC; Fuller GN; Bell ME
    J Neurochem; 1979 May; 32(5):1579-82. PubMed ID: 438825
    [No Abstract]   [Full Text] [Related]  

  • 44. Incorporation of radiophosphate in the inorganic and organic acid-soluble phosphate fractions of the rat sciatic nerve during Wallerian degeneration. I. After nerve section (neurotmesis).
    Gueuning C; Graff GL
    Biomedicine; 1974 Nov; 20(6):425-30. PubMed ID: 4457152
    [No Abstract]   [Full Text] [Related]  

  • 45. The fate of axonal debris in Wallerian degeneration of rat optic and sciatic nerves. Electron microscopy and immunofluorescence studies with neurofilament antisera.
    Bignami A; Dahl D; Nguyen BT; Crosby CJ
    J Neuropathol Exp Neurol; 1981 Sep; 40(5):537-50. PubMed ID: 7024479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An immunohistochemical study of phospholipase A2 in peripheral nerve during Wallerian degeneration.
    Paul JA; Gregson NA
    J Neuroimmunol; 1992 Jul; 39(1-2):31-47. PubMed ID: 1619038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration.
    Perrin FE; Lacroix S; Avilés-Trigueros M; David S
    Brain; 2005 Apr; 128(Pt 4):854-66. PubMed ID: 15689362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelin proteins in Wallerian degeneration of the optic nerve.
    Wender M; Zgorzalewicz B; Sniatała-Kamasa M; Piechowski A
    Exp Pathol; 1983; 23(4):215-7. PubMed ID: 6683664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism of phosphate and sulfate groups modifying the P0 protein of peripheral nervous system myelin.
    Toews AD; Fischer HR; Goodrum JF; Windes S; Morell P
    J Neurochem; 1987 Mar; 48(3):883-7. PubMed ID: 2433400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration of sulfatide synthesis in control and Trembler mice during Wallerian degeneration and remyelination.
    Bourre JM; Dumont O; Gumpel M; Cassagne C
    Neurochem Pathol; 1984; 2(3):153-61. PubMed ID: 6537467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoneurial fluid pressure in wallerian degeneration.
    Powell HC; Myers RR; Costello ML; Lampert PW
    Ann Neurol; 1979 Jun; 5(6):550-7. PubMed ID: 475350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in water diffusion due to Wallerian degeneration in peripheral nerve.
    Beaulieu C; Does MD; Snyder RE; Allen PS
    Magn Reson Med; 1996 Oct; 36(4):627-31. PubMed ID: 8892217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myelin protein metabolism in demyelination and remyelination in the sciatic nerve.
    Smith ME; Kocsis JD; Waxman SG
    Brain Res; 1983 Jun; 270(1):37-44. PubMed ID: 6871715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Wallerian degeneration of the rat sciatic nerve. Lack of effect of cycloheximide and of actinomycin D on the increase of radiophosphate incorporation in acid soluble phosphates observed after section of the nerve].
    Gueuning C; Graff GL
    C R Seances Soc Biol Fil; 1975; 169(3):712-7. PubMed ID: 129222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histochemistry of myelin. XV. Changes in the myelin proteins of the peripheral nerve undergoing Wallerian degeneration--electrophoretic and microdensitometric observations.
    Adams CW; Csejtey J; Hallpike JF; Bayliss OB
    J Neurochem; 1972 Sep; 19(9):2043-8. PubMed ID: 5072382
    [No Abstract]   [Full Text] [Related]  

  • 56. Ganglioside composition of peripheral nerve undergoing Wallerian degeneration.
    Yates AJ; Thompson DK
    J Neurochem; 1978 Jun; 30(6):1649-51. PubMed ID: 671011
    [No Abstract]   [Full Text] [Related]  

  • 57. Leucine and fucose incorporation into odontoblast protein.
    Jontell M; Linde A; Röckert H
    Scand J Dent Res; 1975 Mar; 83(2):67-74. PubMed ID: 1056086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelin phagocytosis in Wallerian degeneration. Properties of millipore diffusion chambers and immunohistochemical identification of cell populations.
    Scheidt P; Friede RL
    Acta Neuropathol; 1987; 75(1):77-84. PubMed ID: 3434217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of myelination: axons not required for the biosynthesis of basal levels of the major myelin glycoprotein by Schwann cells in denervated distal segments of the adult cat sciatic nerve.
    Poduslo JF; Berg CT; Ross SM; Spencer PS
    J Neurosci Res; 1985; 14(2):177-85. PubMed ID: 2413224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Axonal transport and metabolism of glycoproteins in rat sciatic nerve.
    Toews AD; Saunders BF; Morell P
    J Neurochem; 1982 Nov; 39(5):1348-55. PubMed ID: 6181203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.